CompletedNot Applicable

Interscalene Block Versus Serratus Posterior Superior Intercostal Plane Block for Arthroscopic Shoulder Surgery

Turkey (Türkiye)60 participantsStarted 2024-12-01

Plain-language summary

This randomized controlled trial aims to compare the effectiveness of interscalene (ISB) and serratus posterior superior intercostal plane block (SPSIP) for postoperative analgesia in patients undergoing elective arthroscopic shoulder surgery. The primary outcome is total 24-hour opioid consumption. Secondary outcomes include pain scores, hemidiaphragmatic paresis incidence and severity, duration of analgesia, and changes in lung function. Participants are randomized into ISB or SPSIP groups; blocks are performed under ultrasound guidance. Postoperative pain is managed with patient controlled analgesia(PCA).

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Agreeing to participate in the study * The American Society of Anesthesiologists I-III * Scheduled for elective unilateral arthroscopic shoulder surgery Exclusion Criteria: * Refusal to participate in the study * Allergy to the medications to be used * History of serious heart, kidney or liver disease * Neurological deficits or neuropathy * History of anticoagulant use * Pre-existing operative respiratory dysfunction * Having chronic shoulder pain * Being about to undergo open surgery

What they're measuring

Total 24-Hour Postoperative Opioid Consumption

Timeframe: 0-24 hours postoperatively

Trial details

NCT IDNCT07311096

SponsorErzurum Regional Training & Research Hospital

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2025-12-01

View on ClinicalTrials.gov More Shoulder Pain trials